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Simultaneous determination of oxalate, citrate and sulfate in children’s
plasma with ion chromatography. Technical Note. To improve our under-
standing of both diagnosis and treatment of diseases of oxalate metabo-
lism, we first set out to establish a new ion-chromatographic method to
determine normal plasma levels of oxalate, citrate and sulfate from single
plasma samples. In 50 infants and children (23 girls, 27 boys, aged 0.2 to
17 years) with normal renal function, blood was drawn in Li-heparin tubes,
placed on ice and preserved immediately with 40 ml 1 M HCl/ml plasma in
two ultracentrifugation steps. For measurement, plasma was injected onto
an ion chromatography system with NaOH as the mobile phase, and then
run as a linear gradient from 5 mM to 52.5 mM over 21 minutes. Analysis
yielded measurable and reproducible oxalate (6.43 6 1.06 mM/liter),
citrate (79.3 6 27.4 mM/liter) and sulfate (235.0 6 85.3 mM/liter) levels,
without any age and gender specific differences. The least detectable
plasma oxalate level was , 0.3 mM with a high reliability and reproduc-
ibility (coefficient of variance 1.95 to 4.75%). In conclusion, we established
a reproducible, precise method to determine the relevant plasma anions
involved in mineral metabolism, which heretofore have not been easily
measurable. Studies of diseases of oxalate and citrate metabolism are
ongoing on the basis of the normal plasma values achieved in this study.
Determination of urinary lithogenic and stone inhibitory sub-
stances has proven useful in understanding the metabolic causes
of nephrolithiasis [1, 2]. To date, no simple methods have existed
for the determination of some of these substances in plasma. Such
measurements may have relevance in disorders of oxalate metab-
olism, or in renal tubular derangements associated with changes in
urinary citrate excretion and urinary acid-base regulation.
Knowledge of the concentration of urinary cations and anions
involved in stone disease has allowed the calculation of the
urinary saturation by computer-based methodologies [3]. The
saturation level of specific substances, such as calcium-oxalate, has
been linked to the likelihood of subsequent risk of crystal
formation and aggregation [1, 2]. Similarly, changes in plasma
saturation kinetics may be important to children with altered renal
function, since there may be progressive crystal deposition in soft
tissue spaces in patients with chronic renal insufficiency [4].
To better understand the diagnosis and treatment of such
disorders, we set out first to establish a new ion chromatographic
method for the simultaneous determination of oxalate, citrate and
sulfate from single plasma samples. This study presents our new
method as well as data on normal levels of these plasma anions in
healthy infants and children.
METHODS
Blood was obtained from 50 infants and children (23 girls, 27
boys, aged 0.2 to 17 years; Table 1) with normal renal function,
after obtaining informed consent at the Children’s Memorial
Hospital in Chicago, Illinois, USA (N 5 15) and the University
Children’s Hospital in Hamburg, Germany (N 5 35). Infants and
children with known renal diseases, intestinal disorders, and
medications possibly interfering with oxalate or citrate metabo-
lism were not eligible for the study. Dietary intakes were not
restricted.
To hinder the in vitro neogenesis of oxalate, lithium-hepa-
rinized blood (3 ml) was placed directly on ice and immediately
centrifuged at 1000 3 g for five minutes at 4°C, within 10 minutes
of venipuncture. Plasma was then ultrafiltered at 1500 3 g for 20
minutes at 4°C using a Centrisart I ultrafiltration vial (Sartorius
Co., NY, USA). Plasma was placed in the outer chamber and 40
ml of 1 M HCl per ml plasma was added in the inner chamber to
ensure simultaneous acidification of the ultrafiltrate (pH , 1.8)
[5].
We tested the necessity of simultaneous acidification by split-
ting four samples. Instead of the second ultracentrifugation step
mentioned above, plasma from these samples was split, placed on
ice and was only acidified with concentrated HCl to a pH below
2.7.
All plasma samples were stored at 220°C until analysis. Plasma
analysis was performed at the Children’s Memorial Hospital in
Chicago, and therefore all samples from Germany were packed on
dry ice and sent via express mail to the analyzing lab. All samples
included in the study were adequately frozen at arrival.
For measurement of plasma oxalate (Pox), citrate (Pcit), sulfate
(Psulf) and phosphate, plasma was diluted with 0.3 mM H3BO3 (1:5
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or 1:10) and injected automatically onto an ion chromatography
system (DX-500; Dionex Corp., Sunnyvale, CA, USA), equipped
with an analytical column (AS11) and a guard-column (AG11) as
the stationary phase. The mobile phase was NaOH; the 50%
solution (J.T. Baker, Phillipsburg, NJ, USA) was diluted with
water (. 17.5 megaohm resistance) to concentrations of 5 mM and
100 mM. The NaOH was continuously degassed with N2, and run
at 5 mM through 10 minutes, and then as a linear gradient from 5
mM to 52.5 mM through 21 minutes. The eluent background
conductivity was suppressed with an anion self-regenerating sup-
pressor (ASRS-I; Dionex Corp.) to a level below 3 mS at the
highest sodium hydroxide concentration. Computer-based soft-
ware (Peaknet; Dionex Corp.) was used to calculate the concen-
tration of the measured anion peaks (Fig. 1). Aqueous calibration
standards (0.625 to 10 mM for oxalate, 0.625 to 10 mM for citrate
and 1.25 to 20 mM for sulfate and phosphate) were run daily.
Aqueous controls (2.5 and 7.5 mM) of each analyte were run
before and after analysis of the plasma samples.
Since our calibrations and controls were aqueous, we measured
oxalate, citrate and sulfate repetitively in a single plasma sample,
and this was viewed as a baseline value. To that sample, we added
known quantities of oxalate, citrate and sulfate (110, 120, 150
mmol/liter) and remeasured these specimens multiple times (N 5
7).
To establish the reliability and reproducibility of the method,
multiple (33) determinations of oxalate, citrate, and sulfate (as
well as phosphate, whose levels served as internal patient con-
trols) were performed from the first 29 plasma samples obtained.
In addition to the plasma anion concentrations, serum levels of
total calcium, phosphorus, magnesium, sodium, potassium, chlo-
ride, bicarbonate and the free-flowing venous pH were measured
in each participant by standard laboratory procedure [6]. Serum
creatinine was determined using a modified Jaffe´ method and
glomerular filtration rate was calculated using the formula of
Schwartz et al [7].
Results of plasma anion levels are expressed as mmol/liter 6 SD.
Linear regression analysis was performed between plasma anion
concentrations and all other parameters.
The study was approved by the Institutional Review Board of
the Children’s Memorial Hospital in Chicago, Illinois, USA.
RESULTS
Specimens from 50 participants (23 girls, 27 boys) with normal
renal function were eligible for analyses (Table 1). An additional
8 samples were not preserved correctly at the time of initial
venipuncture, or were thawed long before analysis. Measurements
made in the excluded samples showed Pox values to be 17 to 28%
higher than the established upper normal level from samples
correctly processed (data not shown). Pox obtained in samples
preserved without the second step of centrifugation was consid-
erably higher compared to the adequately preserved samples (8.6
vs. 5.0 mmol/liter; 10.8 vs. 7.3 mmol/liter; 8.8 vs. 7.5 mmol/liter; 6.6
vs. 5.9 mmol/liter). A difference in plasma citrate and sulfate levels
was not observed. All values presented represent measurements
made on plasma samples that had the ultrafiltrate acidified.
Multiple determinations of individual plasma anion levels re-
vealed a high degree of reproducibility for each and a low
variation for all plasma anions (Table 2). Phosphorus levels, which
were determined as internal control of validity, were within the
normal age related values for each child (data not shown) [8]; as
a group, values decreased from infancy to adolescence. Plasma
phosphorus levels determined by ion chromatography were com-
parable to those values obtained by a phosphomolybdate reaction
monitored spectrophotometrically (r2 5 0.92, P , 0.03).
Multiple determinations of plasma controls and added concen-
trations (110 mmol, 1 20 mmol, 1 50 mmol) of either oxalate,
citrate and sulfate yielded complete concordance with added and
measured concentrations (Table 3).
The mean levels for plasma oxalate, for plasma citrate and for
plasma sulfate did not differ based on age or gender (Table 4 and
Fig. 2).
In normal children, plasma citrate levels correlated with both
venous pH (r 5 0.42, P , 0.03) and serum bicarbonate (r 5 0.40,
P , 0.03). No correlation was found between serum potassium
and plasma citrate (r 5 0.05). There was no correlation between
plasma sulfate and any parameter studied. Venous pH (range 7.34
to 7.41), as well as serum bicarbonate levels (range 21.0 to 26.4
mmol/liter) were normal for age in each participant.
DISCUSSION
We established a precise and reproducible method for the
determination of relevant plasma anions involved in mineral
metabolism and in the pathogenesis of nephrolithiasis/nephrocal-
cinosis. We demonstrated that plasma preservation and adequate
storage are crucial for plasma oxalate determination. We derived
normal values for plasma oxalate, citrate and sulfate that are
independent of age and gender.
Using previous methods these plasma anions were not easily
measurable. Plasma oxalate determinations have been found to be
very unreliable, especially in the very low normal ranges reported
here. Experiments with plasma oxalate determination have shown
increases in apparent oxalate concentration secondary to oxalate
neogenesis. Thus, in 1980 Akcay and Rose found Pox values
ranging from 1 to 16 mmol/liter in inadequately preserved sam-
ples, possibly due to the oxidation of glyoxylate to oxalate [9].
Values clearly decreased (0.0 to 5.4 mmol/liter) when inhibitors of
this reaction were added. We also observed that plasma has to be
very carefully preserved to ensure a reliable plasma oxalate
determination. Pox levels obtained in thawed plasma samples were
clearly elevated. Additionally, samples without a second centrifu-
gation step for simultaneous acidification showed notably higher
Pox values.
The ion chromatographic method described in this study was
found to be both reproducible and reliable with low coefficients of
variation for all anions (Table 2). We measured plasma phospho-
rus simultaneously by this method, on the same samples as an
internal control, and found values comparable to plasma phos-
phosphorus levels determined in standard fashion by a phospho-
molybdate reaction, and within the normal age-related range for
Table 1. Selected characteristics of study participants
Gender N Age years SCr mg/dl
GFR
ml/min/1.73 m2
Male 27 11.1 (0.2–17) 0.70 (0.25–1.0) 106.8 (74.3–157.8)
Female 23 6.75 (0.3–15.1) 0.60 (0.3–0.8) 119.5 (89.4–151)
Values reported are median (range). Glomerular filtration rate (GFR)
is calculated by the method of Schwartz et al [7]. SCr is serum creatinine.
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each participant. Therefore, we believe our values for oxalate,
citrate and sulfate are valid for normative data. Such plasma
analyses may give additional information about the underlying
pathophysiology of several diseases which cause nephrolithiasis,
or might be helpful in the diagnosis of primary hyperoxaluria or
renal tubular derangements with changes in citrate excretion and
pH regulation.
There are a number of reported plasma oxalate levels in normal
adults, using different analytical methods that include gas chro-
matography, oxalate oxidase or other types of ion chromatography
[10–17]. Pox values range from 0.6 to 2.8 mmol/liter (oxalate
oxidase) [10] up to 6.75 6 2.62 mmol/liter using ion chromatog-
raphy [13]. Our values of 6.43 6 1.06 mmol/liter would therefore
fit in this spectrum, but would nevertheless be located at the upper
range of the values achieved by other methods, and in adults.
Clearly, lower values in healthy children (ranging from 0.78 to
3.02 mmol/liter with a geometric mean of 1.53 mmol/liter) were
reported by Barratt et al [18]. This discrepancy between their
values and those reported here is most likely due to methodolog-
ical differences, as they employed an enzymatic assay using
oxalate oxidase for Pox determination [18]. We can eliminate the
concern that oxalate neogenesis induced an increase in Pox in our
samples, since sample preservation started within 10 minutes after
blood was withdrawn and equivalent Pox levels were obtained in
Fig. 1. Typical ion chromatogram for plasma oxalate, citrate and sulfate determination. Phosphate was run as an internal control; peaks without
standard calibrations are not labeled.
Table 2. Coefficients of variation for plasma analytes
Plasma
anions
% Variation
mean (range) N
Oxalate 2.55 (1.95–4.75) 29
Citrate 3.62 (1.7–5.95) 29
Sulfate 5.15 (2.75–8.25) 29
Phosphate 6.67 (3.25–10.06) 29
Table 3. Repeated determination (N 5 7) of plasma controls and
simultaneously added known quantities of oxalate, citrate and sulfate
(1 10, 1 20 and 1 50 mmol)
Oxalate Citrate Sulfate
mmol/liter
Plasma control 7.1 (0.2) 54.2 (0.8) 215.5 (3.3)
1 10 mmol/liter 17.1 (1.3) 64.9 (0.6) 227.4 (3.6)
1 20 mmol/liter 27.3 (0.8) 74.8 (1.9) 237.0 (3.1)
1 50 mmol/liter 57.6 (2.2) 104.6 (3.6) 267.5 (5.2)
Values reported are mean (SD).
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29 samples with multiple determinations over 21 days, once
preserved.
Kasidas and Rose reported gender specific differences in Pox
levels, with significantly higher values in females [15], but we and
others cannot support their findings [10–14, 16–18]. Also, we
could not demonstrate any age related variations, which, in
contrast, have been found for urinary oxalate/creatinine ratios in
infancy and childhood [19].
Citric acid, a tricarboxylic acid, is a very potent inhibitor of
urinary calcium-oxalate and calcium-phosphate crystallization.
Much of the plasma citrate is complexed to calcium, magnesium
and sodium, while bone is the other major reservoir of (plasma)
citrate [20]. Therefore, the mean Pcit levels reported in adults
were relatively low (100 mmol/liter) [21]. Increases in plasma
citrate levels were observed after exercising, ingestion of an oral
citrate load and after prolonged fasting [22–24].
Normal values of plasma citrate in infants and children have not
previously been published. The mean (free) plasma citrate levels
of 79.3 6 27.4 mmol/liter determined in our study are comparable
to the values previously obtained in adults [21]. All of our children
studied were normal with respect to acid-base homeostasis. Even
so, we observed a positive correlation between both venous pH
and serum bicarbonate to measured plasma citrate levels. These
correlations might not be of great clinical importance, as plasma
citrate has relatively little influence on renal tubular citrate
handling and therefore urinary citrate excretion [25, 26]. Ongoing
studies will attempt to elucidate the influence of plasma citrate
levels on plasma saturation in patients with oxalosis and in
patients with end-stage renal disease.
Inorganic plasma sulfate derives from the metabolism of sulfur
containing amino acids. Sulfate is normally excreted completely
via the kidney, or incorporated into glycosaminoglycans and
sulfatides. Plasma levels for inorganic sulfate in childhood were
reported by Michalk and Manz [27], who found mean plasma
sulfate levels of 241 6 59 mmol/liter, which are comparable to the
levels found in our study. Cole et al observed higher plasma
sulfate levels in neonates during the first weeks of life (471 6 24
mmol/liter) [28]. An increase in plasma sulfate concentration was
found in chronic renal insufficiency [29], although its significance
remains uncertain at present.
In conclusion, we established a reliable and reproducible ion
chromatographic method for the simultaneous determination of
plasma anions with minimal blood volume requirements. Normal
values for plasma oxalate, citrate and sulfate were determined for
healthy infants and children. Using these results, we can now
study the role of plasma anions in disorders of oxalate metabo-
lism, or renal tubular derangements with changes in urinary
citrate excretion and systemic pH regulation.
Fig. 2. Plasma oxalate (A), citrate (B) and sulfate (C) concentrations
(mmol/liter) as a function of age in 50 children. There is a lack of
significant correlation: in A, r 5 0.01; in B, r 5 0.06; in C, r 5 0.11. The
long dash represents the 95% confidence interval and the medium dash is
the prediction interval.
Table 4. Normative data for plasma oxalate, citrate and sulfate levels
in children
Oxalate Citrate Sulfate
mmol/liter
Male 6.63 (1.09) 81.9 (29.2) 211.2 (87)
Female 6.20 (1.06) 76.3 (25.6) 258.3 (80.1)
Mean 6.43 (1.06) 79.3 (27.4) 235.0 (85.3)
Data are mean (SD).
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